Detection of insulin resistance in overweight and obese individuals
DOI:
https://doi.org/10.15218/zjms.2011.0012Keywords:
Fasting serum insulin, blood glucose, fasting serum (TC, TG and HDL)Abstract
Background and objectives: This study was designed mainly to determine fasting serum insulin level and other parameters related to obesity, since Type II diabetes mellitus is the most prevalent problem associated with obesity. In Kurdish region, no previous studies about insulin essay in overweight and obese individuals have been executed. Measuring insulin level in overweight and obese individuals can give information about the body's sensitivity to insulin.
Methods: Fasting blood samples were derived from (60) overweight individuals (30 males + 30 females) and from (30) normal weight individuals and were analyzed for insulin level by using an immuno assay method (ELISA method) whereas fasting blood glucose, Triglyceride(TG), Total Cholesterol(TC). High Density Lipoprotein(HDL), were estimated spectrophotometrically.
Results: From total (60) overweight individuals 76.6% have insulin resistance. From this percent about 52% of those individuals were with family history of diabetes and 24% were with family history of obesity.
Conclusion: Three relatively simple metabolic markers can identify overweight and obese individuals who are sufficiently insulin resistant to be at increased risk for various adverse outcomes are (TG level, ratio of TG to HDL, and insulin level).
Metrics
References
- Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabetes Med 2002; 19(7):527 – 134.
- Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595 – 1607.
- Haffner SM. The prediabetic problem: Development of non- insulin- dependent diabetes mellitus and related abnormalities. J Diabetes Complications 1997; 11: 69 – 76.
- Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C. Insulin Resistance and insulin secretory dysfunction as Precursor of non-insulin-dependent diabetes mellitus: Prospective studies of Pima Indians. N Eng 1 J Med 1993; 329: 1988 – 1992.
- Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia the key feature of a cardiovascular and metabolic syndrome diabetologia 1991; 34: 416-422.
- Centers for Disease Control and Prevention. National Diabetes Fact sheet, United States, 2005. [Cited 2006, Nov 3]. Available from: http://www.cdc.gov/diabetes/pubs/ Pdf/ndfs – 2005.
- Tracey McLaughlin, Fahim Abbasi, Karen Cheal, James Chu, Cindy Lamerdola, Gerald Reaven. Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant. 2003; 139: 802 – 809.
- Grundy SM, Hansen B, Smith Sc. Clinical management of metabolic syndrome: report of the American Heart Association Conference on Scientific issues related to management circulation. 2004 Feb 3 ; 109(4):551 – 556.
- Bramnert M, Segerlantz M, Laurila E, Daugaard JR, Manhem P, Groop L “Growth hormone replacement therapy induces insulin resistance by activating the glucose- fatty acid cycle 2003.(http://jcem.endojournal, org/cgi/”).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2011 Leweza B. Abbass, Fargeen Ezzaddin (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in Zanco J Med Sci is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0).
